Raras
Buscar doenças, sintomas, genes...
Síndrome do hamartoma PTEN
ORPHA:306498CID-10 · Q85.8CID-11 · LD2D.YDOENÇA RARA

É uma síndrome genética de herança dominante, o que significa que basta herdar uma cópia alterada do gene de um dos pais para ter a condição. Ela é causada por alterações (mutações) no gene PTEN que provocam a doença. A síndrome é caracterizada por crescimentos benignos de tecido (não cancerosos, chamados hamartomas), crescimento excessivo de certas partes do corpo, e transtornos do neurodesenvolvimento (problemas no desenvolvimento do cérebro). Também há um risco maior de desenvolver vários tipos de câncer, incluindo câncer de mama, tireoide e de endométrio (o revestimento interno do útero). A PHTS abrange a Síndrome de Cowden, a Síndrome de Bannayan-Riley-Ruvalcaba e a Síndrome de Proteus-like.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma síndrome genética de herança dominante, o que significa que basta herdar uma cópia alterada do gene de um dos pais para ter a condição. Ela é causada por alterações (mutações) no gene PTEN que provocam a doença. A síndrome é caracterizada por crescimentos benignos de tecido (não cancerosos, chamados hamartomas), crescimento excessivo de certas partes do corpo, e transtornos do neurodesenvolvimento (problemas no desenvolvimento do cérebro). Também há um risco maior de desenvolver vários tipos de câncer, incluindo câncer de mama, tireoide e de endométrio (o revestimento interno do útero). A PHTS abrange a Síndrome de Cowden, a Síndrome de Bannayan-Riley-Ruvalcaba e a Síndrome de Proteus-like.

Pesquisas ativas
4 ensaios
10 total registrados no ClinicalTrials.gov
Publicações científicas
336 artigos
Último publicado: 2026 Apr 13

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
9.0
Worldwide
Início
All ages
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q85.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
29 sintomas
🧬
Pele e cabelo
18 sintomas
😀
Face
17 sintomas
👁️
Olhos
13 sintomas
📏
Crescimento
10 sintomas
🧠
Neurológico
8 sintomas

+ 57 sintomas em outras categorias

Características mais comuns

Boca aberta
Adenoma de células basais salivar
Morfologia anormal do sistema cardiovascular
Canal auditivo interno estreito
Trombose arterial
Clinodactilia do quinto dedo
189sintomas
Sem dados (189)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 189 características clínicas mais associadas, ordenadas por frequência.

Boca abertaOpen mouth
Adenoma de células basais salivarSalivary basal cell adenoma
Morfologia anormal do sistema cardiovascularAbnormal cardiovascular system morphology
Canal auditivo interno estreitoNarrow internal auditory canal
Trombose arterialArterial thrombosis

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico336PubMed
Últimos 10 anos200publicações
Pico202550 papers
Linha do tempo
2026Hoje · 2026🧪 2008Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant.

AKT1RAC-alpha serine/threonine-protein kinaseDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMe

LOCALIZAÇÃO

CytoplasmNucleusCell membraneMitochondrion intermembrane space

VIAS BIOLÓGICAS (7)
CD28 dependent PI3K/Akt signalingVEGFR2 mediated vascular permeabilityPIP3 activates AKT signalingNegative regulation of the PI3K/AKT networkG beta:gamma signalling through PI3Kgamma
MECANISMO DE DOENÇA

Breast cancer

A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.

OUTRAS DOENÇAS (7)
ovarian cancerProteus syndromehereditary breast carcinomacolorectal cancer
HGNC:391UniProt:P31749
PTENPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTENDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Dual-specificity protein phosphatase, dephosphorylating tyrosine-, serine- and threonine-phosphorylated proteins (PubMed:9187108, PubMed:9256433, PubMed:9616126). Also functions as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring of PtdIns(3,4,5)P3/phosphatidylinositol 3,4,5-trisphosphate, PtdIns(3,4)P2/phosphatidylinositol 3,4-diphosphate and PtdIns3P/phosphatidylinositol 3-phosphate with a preference for PtdIns(3,4,5)P3 (PubMed:16824732, PubMed:26504226, PubM

LOCALIZAÇÃO

CytoplasmNucleusNucleus, PML bodyCell projection, dendritic spinePostsynaptic densitySecreted

VIAS BIOLÓGICAS (10)
Synthesis of PIPs at the plasma membraneDownstream TCR signalingNegative regulation of the PI3K/AKT networkTP53 Regulates Metabolic GenesSynthesis of IP3 and IP4 in the cytosol
MECANISMO DE DOENÇA

Cowden syndrome 1

An autosomal dominant hamartomatous polyposis syndrome with age-related penetrance. Cowden syndrome is characterized by hamartomatous lesions affecting derivatives of ectodermal, mesodermal and endodermal layers, macrocephaly, facial trichilemmomas (benign tumors of the hair follicle infundibulum), acral keratoses, papillomatous papules, and elevated risk for development of several types of malignancy, particularly breast carcinoma in women and thyroid carcinoma in both men and women. Colon cancer and renal cell carcinoma have also been reported. Hamartomas can be found in virtually every organ, but most commonly in the skin, gastrointestinal tract, breast and thyroid.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
62.5 TPM
Cervix Ectocervix
62.4 TPM
Cervix Endocervix
59.7 TPM
Fallopian Tube
51.0 TPM
Cérebro - Hemisfério cerebelar
49.1 TPM
OUTRAS DOENÇAS (19)
Cowden syndrome 1prostate cancer, hereditaryPTEN hamartoma tumor syndromemacrocephaly-autism syndrome
HGNC:9588UniProt:P60484

Variantes genéticas (ClinVar)

2,050 variantes patogênicas registradas no ClinVar.

🧬 AKT1: GRCh37/hg19 14q32.2-32.33(chr14:97521552-107285437)x3 ()
🧬 AKT1: GRCh37/hg19 14q32.2-32.33(chr14:101180490-106329074)x1 ()
🧬 AKT1: NM_001382430.1(AKT1):c.16A>C (p.Ile6Leu) ()
🧬 AKT1: NM_001382430.1(AKT1):c.286_287del (p.Arg96fs) ()
🧬 AKT1: NM_001382430.1(AKT1):c.237G>C (p.Gln79His) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 2,129 variantes classificadas pelo ClinVar.

213
1597
319
Patogênica (10.0%)
VUS (75.0%)
Benigna (15.0%)
VARIANTES MAIS SIGNIFICATIVAS
PTEN: NM_000314.8(PTEN):c.342dup (p.Asp115fs) [Likely pathogenic]
PTEN: NM_000314.8(PTEN):c.95T>G (p.Ile32Ser) [Likely pathogenic]
PTEN: NM_000314.8(PTEN):c.956C>G (p.Thr319Ser) [Uncertain significance]
PTEN: NM_000314.8(PTEN):c.80-10A>G [Uncertain significance]
PTEN: NM_000314.8(PTEN):c.1201A>G (p.Thr401Ala) [Uncertain significance]

Vias biológicas (Reactome)

40 vias biológicas associadas aos genes desta condição.

Activation of BAD and translocation to mitochondria PIP3 activates AKT signaling Downregulation of ERBB2:ERBB3 signaling Translocation of SLC2A4 (GLUT4) to the plasma membrane Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation MTOR signalling AKT phosphorylates targets in the cytosol AKT phosphorylates targets in the nucleus Negative regulation of the PI3K/AKT network eNOS activation AKT-mediated inactivation of FOXO1A Integrin signaling Deactivation of the beta-catenin transactivating complex CD28 dependent PI3K/Akt signaling Co-inhibition by CTLA4 G beta:gamma signalling through PI3Kgamma Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA KSRP (KHSRP) binds and destabilizes mRNA VEGFR2 mediated vascular permeability TP53 Regulates Metabolic Genes Constitutive Signaling by AKT1 E17K in Cancer Interleukin-4 and Interleukin-13 signaling Regulation of TP53 Degradation Regulation of TP53 Activity through Acetylation Regulation of TP53 Activity through Association with Co-factors PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Cyclin E associated events during G1/S transition Cyclin A:Cdk2-associated events at S phase entry PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 RAB GEFs exchange GTP for GDP on RABs Synthesis of PIPs at the plasma membrane Synthesis of IP3 and IP4 in the cytosol Downstream TCR signaling PTEN Loss of Function in Cancer Ub-specific processing proteases Ovarian tumor domain proteases Regulation of PTEN mRNA translation Regulation of PTEN localization Regulation of PTEN stability and activity Transcriptional Regulation by MECP2

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 23
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 9 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome do hamartoma PTEN

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

3 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

10 ensaios clínicos encontrados, 4 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
271 papers (10 anos)
#1

Epilepsy in pediatric patients with PTEN hamartoma tumor syndrome: First step in recommendations for clinical management.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society2026 Mar 09

PTEN Hamartoma Tumor Syndrome (PHTS) is an autosomal dominant syndrome caused by a mutation in the PTEN gene. Previous studies have suggested an association between PHTS and epilepsy, but the clinical characteristics of epilepsy in PHTS remain unknown. This study aims to expand knowledge of epilepsy in PHTS and provide insights into its clinical features. A retrospective observational study was conducted at the Radboud University Medical Center, including 149 patients with clinically or genetically confirmed PHTS. Electronic patient records were reviewed for baseline characteristics, epileptic features, therapeutic interventions, and neuroimaging results. A cumulative risk analysis for developing epilepsy was performed. The prevalence of epilepsy among PHTS patients in this cohort was found to be 6%, with an estimated PHTS prevalence of 1:20 000 in the Netherlands. Autism spectrum disorder (ASD) was significantly associated with an increased risk of developing epilepsy (p = 0.002). A range of seizure semiologies was observed, with focal epilepsy being the most common, presenting as focal seizures with impaired awareness. EEG results predominantly showed (multi)focal discharges with variable localization. MRI abnormalities did not correlate with epileptic foci on EEG. This study highlights the clinical characteristics of epilepsy in pediatric patients with PHTS. Follow-up should include monitoring for characteristics of focal epilepsy, with EEG utilized selectively when such episodes are observed, rather than as a routine screening measure. Treatment strategies should be individualized based on the patient's characteristics. In cases of epilepsy, MRI is recommended to identify potential structural malformations amenable to surgical intervention.

#2

Cerebrovascular Malformations Associated With Hereditary Hemorrhagic Telangiectasia and HHT-Like Syndromes: A Comparative Overview.

European journal of neurology2026 Feb

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder marked by mucocutaneous telangiectasias, recurrent epistaxis, and visceral arteriovenous malformations (AVMs). Neurologic risks include brain AVMs and hemorrhagic stroke. Several rare genetic and sporadic syndromes ("HHT-like" syndromes) share overlapping vascular features, complicating diagnosis. Differentiating these conditions is essential for accurate neurovascular risk assessment. A comprehensive literature review (PubMed, Scopus, Embase, Google Scholar; 1990-2025) targeted cerebrovascular manifestations of HHT and related syndromes. Key entities included Wyburn-Mason syndrome, Cobb syndrome, Klippel-Trénaunay syndrome (KTS), neurofibromatosis type 1 (NF1), PHACE(S) syndrome, capillary malformation-AVM (CM-AVM), Parkes Weber syndrome (PWS), juvenile polyposis/HHT overlap (JP-HHT), HHT type 5 (BMP9/GDF2), PTEN hamartoma tumor syndrome (PHTS), and blue rubber bleb nevus syndrome (BRBNS). Data on gene variants, lesion types, neuroimaging, stroke risk, and neurologic outcomes were synthesized. High-flow cerebrovascular malformations similar to HHT are prominent in Wyburn-Mason syndrome, CM-AVM, and PWS, conferring a substantial hemorrhagic stroke risk. NF1 and PHACE(S) primarily feature occlusive arteriopathies linked to ischemic events. KTS, BRBNS, and PHTS predominantly show low- or mixed-flow anomalies with lower CNS hemorrhagic risk but increased thrombotic complications. JP-HHT carries added gastrointestinal cancer risk via SMAD4 variants, while HHT type 5 often presents incompletely. Genetic testing and tailored neuroimaging are critical for differentiation. Although many syndromes mimic HHT, few combine mucosal telangiectasias, high-flow AVMs, and recurrent hemorrhage. Integrating clinical, imaging, and genetic data enables precise diagnosis, risk stratification, and personalized management.

#3

Effects of bariatric surgery in individuals with PTEN Hamartoma Tumor Syndrome (PHTS): A systematic review.

Obesity facts2026 Mar 18

The aim of this systematic review is to provide an overview of the literature on the effects of bariatric surgery in patients with obesity and PTEN (phosphatase and tensin homolog) Hamartoma Tumor Syndrome (PHTS) diagnosis. Two studies were included with a methodological quality ranging from poor to good. Both studies were case reports in young females (<35yo), massive effects on weight loss and HbA1c levels were seen. Bariatric surgery in obese patients with PHTS diagnosis results in significant decrease in weight and complete remission of Diabetes Mellitus Type 2 (DMT2). The effects on thyroid hormones, lipid levels, renal function, and psychological factors after bariatric surgery in PHTS remain unexplored. More research is needed to fully understand how bariatric surgery can take part of the preventative treatment options for PHTS patients with obesity.

#4

Genomic modifiers of malignant and neurodevelopmental phenotypes in individuals with PTEN hamartoma tumor syndrome.

NPJ genomic medicine2026 Mar 17

PTEN hamartoma tumor syndrome (PHTS), caused by germline PTEN variants, exhibits marked phenotypic heterogeneity, most notably cancer, neurodevelopmental disorders (NDD), or both. The basis for this divergence, even among carriers of identical PTEN variants, remains poorly defined. We performed whole-genome sequencing of 599 individuals with PHTS and family members, complemented by analyses of PTEN variant carriers from the All of Us Research Program. Analyses included both targeted evaluation of genes previously implicated in cancer and NDD and agnostic genome-wide single-variant and rare-variant burden testing. The analytic cohort comprised 543 PHTS probands, including individuals with NDD (n = 171), cancer (n = 221), both phenotypes (n = 21), or neither (n = 130) at the time of enrollment. Pathogenic or likely pathogenic variants in cancer-associated genes were identified in 37 (6.8%), most frequently in MITF, DICER1, and BRCA2, while 43 (7.9%) harbored variants in NDD-related genes, including DHCR7, POLG, and ARSA. Such secondary variants were less common in PTEN variant carriers in All of Us. Genome-wide analyses identified candidate modifier loci functionally linked to PTEN, including in ZNF713, TPTE2P1, and PDPK1. These findings demonstrate that PHTS phenotypes are shaped by complex gene-gene interactions beyond PTEN alone, informing mechanisms underlying the cancer-NDD dichotomy and advancing precision risk stratification.

#5

Macrocephaly and Characteristic MRI Findings as Early Clues to a Hereditary Overgrowth Syndrome.

Cureus2026 Jan

Macrocephaly may be the presenting feature of underlying genetic conditions in childhood. We report a five-year-old boy with persistent macrocephaly above +3 standard deviations since infancy and subtle facial dysmorphisms. Neurological examination revealed hypotonia, a wide-based gait, and fine and gross motor difficulties. Developmental assessment confirmed psychomotor delay without features of autism spectrum disorder. Brain MRI revealed multiple enlarged perivascular spaces involving the bilateral subcortical white matter and the corpus callosum, as well as callosal thickening. Genetic testing identified a heterozygous likely pathogenic variant in the PTEN gene, with maternal transmission confirmed on familial testing. Timely genetic diagnosis allows appropriate genetic counselling and clinical follow-up.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC133 artigos no totalmostrando 198

2026

Effects of bariatric surgery in individuals with PTEN Hamartoma Tumor Syndrome (PHTS): A systematic review.

Obesity facts
2026

Genomic modifiers of malignant and neurodevelopmental phenotypes in individuals with PTEN hamartoma tumor syndrome.

NPJ genomic medicine
2026

Epilepsy in pediatric patients with PTEN hamartoma tumor syndrome: First step in recommendations for clinical management.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2026

Macrocephaly and Characteristic MRI Findings as Early Clues to a Hereditary Overgrowth Syndrome.

Cureus
2026

Cerebrovascular Malformations Associated With Hereditary Hemorrhagic Telangiectasia and HHT-Like Syndromes: A Comparative Overview.

European journal of neurology
2026

Cancer predisposition syndromes: an imaging review.

Cancer imaging : the official publication of the International Cancer Imaging Society
2026

Radiation-Induced Papillomas in PTEN Hamartoma Tumor Syndrome.

International journal of dermatology
2026

A Novel PTEN Frameshift Variant in a Child With Autism Spectrum Disorder and Macrocephaly: A Case Report.

Cureus
2026

Population-based Characterization of PTEN Hamartoma Tumor Syndrome.

Research square
2026

Hereditary Renal Cancer Syndromes: Clinicopathologic Features and Correlation With Tumors Harboring Somatic Mutations.

Advances in anatomic pathology
2026

Genetic tumor syndromes in female cancer: insights into inherited cancer predisposition and clinical implications.

Archives of gynecology and obstetrics
2026

Complex Management of High-Flow Gastrointestinal Arteriovenous Malformation With Chronic Portomesenteric Thrombosis in PTEN Hamartoma Tumor Syndrome.

ACG case reports journal
2026

Unmasking familial follicular cell-derived thyroid neoplasms associated with syndromes: DICER1 and PTEN-hamartoma tumor syndromes.

Virchows Archiv : an international journal of pathology
2026

A phase II study of the AKT inhibitor TAS-117 in patients with advanced solid tumors and germline PTEN mutations.

ESMO open
2026

Sensitivity Analysis of the Efficacy of Everolimus for Neurocognitive Symptoms in PTEN Hamartoma Tumor Syndrome.

Advances in therapy
2025

Cowden Syndrome With a Co-existing Lynch Syndrome Risk Mutation.

Cureus
2026

Sirolimus to treat chronic uveitis in PTEN hamartoma tumor syndrome: experience of a target therapy customized on specific disease pathway.

Rheumatology (Oxford, England)
2025

Bannayan-Riley-Ruvalcaba syndrome, etiology, clinical manifestations, diagnostic approaches, and current therapeutic measures: a narrative review.

Discover oncology
2025

Case Report: A case series of Lhermitte-Duclos disease with surgical intervention.

Frontiers in oncology
2025

The genetic puzzle of FAP: exploring novel diagnostic approaches for APC/MUTYH-negative case.

Hereditary cancer in clinical practice
2025

The Value of Punching It Out: Patient With Cowden Syndrome and MALT Lymphoma of the Lung.

Case reports in oncological medicine
2025

Ovarian vascular malformation - clinical presentation of Cowden syndrome.

Ceska gynekologie
2026

Dermatologic Features of Endocrine Tumor Syndromes-Systematic Review and Meta-Analysis.

International journal of dermatology
2025

Paired DNA/RNA testing uncovers a deep intronic PTEN pathogenic variant associated with clinical Cowden Syndrome: a case report.

Frontiers in oncology
2025

Characterizing Key Correlates of Sleep Problems Across Rare Neurodevelopmental Genetic Disorders.

Journal of autism and developmental disorders
2025

Invasive breast carcinoma in a patient with PHTS: a case report.

Diagnostic pathology
2025

Neurodevelopmental and Neurologic Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations.

Neurology. Genetics
2025

Safe Airway Management in a Pediatric Case of PTEN Hamartoma Tumor Syndrome With Multiple Pharyngeal and Laryngeal Polyps: A Case Report.

Cureus
2026

Targeted RNA sequencing of thyroid tumors from individuals with PTEN hamartoma tumor syndrome reveals a unique transcriptome with a predominantly RAS-like expression profile.

Surgery
2026

When Benign Is Not Simple: Suspicious Thyroid Scintigraphy Revealing PTEN Hamartoma Tumor Syndrome in a Pediatric Patient.

Clinical nuclear medicine
2025

Neurobehavioral Signatures in Overgrowth Intellectual Disability Syndromes: Dissecting Genotype-Phenotype Relationships in the PI3K-AKT-MTOR Pathway.

medRxiv : the preprint server for health sciences
2025

Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial Endpoints.

American journal on intellectual and developmental disabilities
2025

PTEN Hamartoma Tumor Syndrome/Cowden Syndrome With Diffuse Sebaceous Gland Hyperplasia: Description of an Atypical Phenotype and a Previously Undescribed Pathogenic Variant.

The Journal of dermatology
2025

Enhancing and leveraging principal investigator and patient advocacy group collaboration in rare disease clinical research-meeting report from the rare Diseases Clinical Research Network.

Therapeutic advances in rare disease
2025

Skin Signals: Exploring the Intersection of Cancer Predisposition Syndromes and Dermatological Manifestations.

International journal of molecular sciences
2025

Paraspinal Arteriovenous Shunt Associated with PTEN Hamartoma Tumor Syndrome: A Case Report and Literature Review.

Acta neurochirurgica. Supplement
2025

[Advance in genetics research on Gastrointestinal polyposis syndromes].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

Multiple Genomic Technologies Validate Rare Novel Variant and Direct Medical Care in Vascular Anomalies.

American journal of medical genetics. Part A
2025

Lessons from the Oncology Clinic: Repurposing PI3K Pathway Inhibitors for the Treatment of PTEN Hamartoma Tumor Syndrome.

Cancer discovery
2025

Atypical Manifestations of Cowden Syndrome in Pediatric Patients.

Diagnostics (Basel, Switzerland)
2025

Hypertrophic Tongue Papillae in Cowden Syndrome/PTEN Hamartoma Tumor Syndrome.

JAMA dermatology
2025

Sirolimus for Colon Polyposis in PTEN Hamartoma Tumor Syndrome.

Clinical and translational gastroenterology
2025

Metastatic Breast Cancer to a Dedifferentiated Solitary Fibrous Tumor Arising from a PTEN Hamartoma of Soft Tissue.

International journal of surgical pathology
2025

The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS).

Genetics in medicine : official journal of the American College of Medical Genetics
2025

Screening at the scope: enhancing the role of pathologists in diagnosing gastrointestinal polyposis syndromes.

Virchows Archiv : an international journal of pathology
2025

Deep Phenotyping of Pathology-Confirmed Benign Lesions in PTEN Hamartoma Tumor Syndrome Patients.

Clinical genetics
2025

Population Prevalence of the Major Thyroid Cancer-Associated Syndromes.

The Journal of clinical endocrinology and metabolism
2025

PTEN and novel TEK germline variants associated with the phenotypes of PTEN hamartoma tumor syndrome.

Genes &amp; diseases
2025

Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome.

Cancer discovery
2025

Papillary Tumor of the Pineal Region Identified by DNA Methylation Leads to the Incidental Finding of Germline Mutation PTEN G132D Associated with PTEN Hamartoma Tumor Syndrome: A Case Report and Systematic Review.

Current oncology (Toronto, Ont.)
2025

Non-serous ovarian cancer in PTEN Hamartoma Tumor Syndrome: additional evidence for increased risk.

Familial cancer
2025

Exploring MRI and Mammography Lesion Features for Breast Cancer Detection in PTEN Hamartoma Tumor Syndrome.

Cancers
2024

Phenotypic Variability of Cowden Syndrome Within a Single Family: Impact on Diagnosis, Management and Genetic Counselling.

Balkan journal of medical genetics : BJMG
2025

A diagnostic challenge: A rare case of PTEN hamartoma of soft tissue of the mental region.

International journal of surgery case reports
2025

Extended spectrum of cancers in PTEN hamartoma tumor syndrome.

NPJ precision oncology
2025

Pancreatic Mixed Acinar-neuroendocrine Carcinoma in a Patient With a Germline PTEN Variant: A Case Report and Genomic Literature Review.

In vivo (Athens, Greece)
2025

Early-Onset Macrosomia, Advanced Brain Maturation, and Gonadoblastoid Testicular Dysplasia in a Fetus With a PTEN Variant.

Prenatal diagnosis
2025

Divergent PTEN-p53 interaction upon DNA damage in a human thyroid organoid model with germline PTEN mutations.

Endocrine-related cancer
2025

Phenotypic rescue via mTOR inhibition in neuron-specific Pten knockout mice reveals AKT and mTORC1-site specific changes.

Molecular psychiatry
2025

Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working Group.

Clinical cancer research : an official journal of the American Association for Cancer Research
2025

Identification of a germline deep intronic PTEN-deletion leading to exonization through whole genome and targeted RNA sequencing.

Familial cancer
2025

Renal Neoplasia: Rare Subtypes and Uncommon Clinical Presentations.

Surgical pathology clinics
2024

Using cortical organoids to understand the pathogenesis of malformations of cortical development.

Frontiers in neuroscience
2025

A Newborn with Cleft Palate Associated with PTEN Hamartoma Tumor Syndrome.

Clinics and practice
2024

Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN
2025

Cancer and disease profiles for PTEN pathogenic variants in Japanese population.

Journal of human genetics
2025

Remote monitoring of social attention in neurogenetic syndromes and idiopathic neurodevelopmental disability.

Autism research : official journal of the International Society for Autism Research
2025

Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician.

World journal of pediatrics : WJP
2025

Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis Complex.

Clinical cancer research : an official journal of the American Association for Cancer Research
2025

Quantifying neurobehavioral profiles across neurodevelopmental genetic syndromes and idiopathic neurodevelopmental disorders.

Developmental medicine and child neurology
2024

Quantitative evaluation of DNA damage repair dynamics to elucidate predictors of autism vs. cancer in individuals with germline PTEN variants.

PLoS computational biology
2024

The Genomic Landscape of Benign and Malignant Thyroid Tumors from Individuals Carrying Germline PTEN Variants Is Distinct from Sporadic Thyroid Cancers.

Cancer research
2024

A systematic review of Bannayan - Riley - Ruvalcaba syndrome.

Scientific reports
2024

Clinical Neurologic Features and Evaluation of PTEN Hamartoma Tumor Syndrome: A Systematic Review.

Neurology
2024

Breast Hamartoma With Synchronous Contralateral Breast Cancer: A Case Report.

Cureus
2024

Potentiation by Protein Synthesis Inducers of Translational Readthrough of Pathogenic Premature Termination Codons in PTEN Isoforms.

Cancers
2024

Sirolimus for vascular anomalies associated with PTEN hamartoma tumor syndrome.

Pediatric blood &amp; cancer
2024

A Bi-Institutional Study of Gastrointestinal and Hepatic Manifestations in Children With PTEN Hamartoma Tumor Syndrome.

Gastro hep advances
2025

Experience in a PTEN Hamartoma Tumor Syndrome Expertise Centre: Yield of Thyroid Ultrasound Surveillance in Children with PTEN Hamartoma Tumor Syndrome.

Journal of clinical research in pediatric endocrinology
2024

Treatment and Diagnostic Approach for Lhermitte-Duclos Disease and Suspected Cowden Syndrome.

Cureus
2024

Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center study.

International journal of cancer
2024

Neuropsychological functioning of adults with PTEN hamartoma tumor syndrome.

American journal of medical genetics. Part A
2024

Facial Features of Hereditary Cancer Predisposition.

JCO oncology practice
2024

Case report: Association between PTEN-gene variant and an aggressive case of multiple dAVFs.

Frontiers in neurology
2024

Developmental and behavioral phenotypes of pediatric patients with PTEN hamartoma tumor syndrome.

American journal of medical genetics. Part A
2024

Exploring the neurological features of individuals with germline PTEN variants: A multicenter study.

Annals of clinical and translational neurology
2024

Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS).

Cancers
2024

PTEN hamartoma tumor syndrome: Clinical and genetic characterization in pediatric patients.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with PTEN hamartoma tumor syndrome.

Cell reports. Medicine
2023

Sinonasal Neuroendocrine Carcinoma in Adult Proteus Syndrome.

Iranian journal of otorhinolaryngology
2024

Germline PTEN genotype-dependent phenotypic divergence during the early neural developmental process of forebrain organoids.

Molecular psychiatry
2023

Differential cell cycle checkpoint evasion by PTEN germline mutations associated with dichotomous phenotypes of cancer versus autism spectrum disorder.

Oncogene
2023

Clinical Guidelines for Diagnosis and Management of Cowden Syndrome/PTEN Hamartoma Tumor Syndrome in Children and Adults-Secondary Publication.

Journal of the anus, rectum and colon
2024

Arteriovenous malformations as a presenting sign of PTEN hamartoma tumor syndrome: A case series.

Pediatric dermatology
2023

Orofacial Manifestations in a Middle-Aged Woman with Cowden Syndrome: A Case Image.

Head and neck pathology
2024

Lack of evidence for germline WWP1 pathogenic variants in gastrointestinal polyposis and other phenotypes suggestive of PTEN-hamartoma-tumor syndrome.

Genes &amp; diseases
2023

Lipomas: genetic basis of common skin lesions and their occurrence in rare diseases.

Postepy dermatologii i alergologii
2023

SHH medulloblastoma and very early onset of bowel polyps in a child with PTEN hamartoma tumor syndrome.

Frontiers in molecular neuroscience
2023

Variants in PTEN Are Associated With a Diverse Spectrum of Cortical Dysplasia.

Pediatric neurology
2023

Development of webcam-collected and artificial-intelligence-derived social and cognitive performance measures for neurodevelopmental genetic syndromes.

American journal of medical genetics. Part C, Seminars in medical genetics
2023

Novel anti-PTEN C2 domain monoclonal antibodies to analyse the expression and function of PTEN isoform variants.

PloS one
2023

Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome.

NPJ genomic medicine
2023

Case Report - Multinodular goiter in a patient with Congenital Hypothyroidism and Bannayan-Riley-Ruvalcaba syndrome: the possible synergic role of TPO and PTEN mutation.

Frontiers in endocrinology
2023

Renal Neoplasia Occurring in Patients With PTEN Hamartoma Tumor Syndrome : Clinicopathologic Study of 12 Renal Cell Carcinomas From 9 Patients and Association With Intrarenal "Lipomas".

The American journal of surgical pathology
2023

Novel dermatological and skeletal features associated with PTEN variant in PTEN hamartoma tumor syndrome.

European journal of medical genetics
2023

Comparing synaptic proteomes across five mouse models for autism reveals converging molecular similarities including deficits in oxidative phosphorylation and Rho GTPase signaling.

Frontiers in aging neuroscience
2023

The mitochondrial genome as a modifier of autism versus cancer phenotypes in PTEN hamartoma tumor syndrome.

HGG advances
2023

Yield of annual endometrial cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.

European journal of medical genetics
2023

Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.

JAMA network open
2022

Case Series: Neurobehavioral Profile of Adolescents with PTEN Hamartoma Tumor Syndrome.

Journal of pediatric neuropsychology
2023

Development of informant-report neurobehavioral survey scales for PTEN hamartoma tumor syndrome and related neurodevelopmental genetic syndromes.

American journal of medical genetics. Part A
2023

A Case of Cowden Syndrome Presenting with Diverse Cutaneous Manifestations.

Annals of dermatology
2023

Thyroid pathology, a clue to PTEN hamartoma tumor syndrome.

Journal of pathology and translational medicine
2023

Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers.

Biomolecules
2023

How PTEN mutations degrade function at the membrane and life expectancy of carriers of mutations in the human brain.

bioRxiv : the preprint server for biology
2023

Clinical Spectrum and Science Behind the Hamartomatous Polyposis Syndromes.

Gastroenterology
2023

Thyroid findings in pediatric and adult patients with PTEN hamartoma tumor syndrome: A retrospective analysis, and literature review.

Endocrine
2022

Gingival Overgrowths Revealing PTEN Hamartoma Tumor Syndrome: Report of Novel PTEN Pathogenic Variants.

Biomedicines
2023

Longitudinal neurobehavioral profiles in children and young adults with PTEN hamartoma tumor syndrome and reliable methods for assessing neurobehavioral change.

Journal of neurodevelopmental disorders
2023

Comparative Protein Structural Network Analysis Reveals C-Terminal Tail Phosphorylation Structural Communication Fingerprint in PTEN-Associated Mutations in Autism and Cancer.

The journal of physical chemistry. B
2023

Occult lipomatosis of the nerve as part of macrodystrophia lipomatosa: illustrative case.

Journal of neurosurgery. Case lessons
2023

Functional analysis of PTEN variants of unknown significance from PHTS patients unveils complex patterns of PTEN biological activity in disease.

European journal of human genetics : EJHG
2022

The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.

Cancer
2023

Benign goiters requiring thyroidectomy as the signal for PTEN hamartoma tumor syndrome diagnosis.

American journal of medical genetics. Part A
2022

New Insights into Melanoma Tumor Syndromes.

JID innovations : skin science from molecules to population health
2022

Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.

European journal of medical genetics
2023

Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.

Journal of the National Cancer Institute
2023

Verrucous epidermal nevus as a manifestation of a type 2 mosaic PTEN mutation in Cowden syndrome.

Pediatric dermatology
2022

Cowden Disease: A Review.

The American Journal of dermatopathology
2022

Sirolimus treatment of a PTEN hamartoma tumor syndrome presenting with melena.

The Turkish journal of pediatrics
2022

Nervous system (NS) Tumors in Cancer Predisposition Syndromes.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
2022

A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN-inactivating mutations.

Future oncology (London, England)
2022

Gastrointestinal manifestations in PTEN hamartoma tumor syndrome.

Best practice &amp; research. Clinical gastroenterology
2022

Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants.

American journal of human genetics
2022

Looking closely at overgrowth: Constitutional mosaicism in PTEN hamartoma tumor syndrome.

Clinical genetics
2022

Development and Progression of Thyroid Disease in PTEN Hamartoma Tumor Syndrome: Refined Surveillance Recommendations.

Thyroid : official journal of the American Thyroid Association
2022

Clinicopathologic features of thyroid nodules with PTEN mutations on preoperative testing.

Endocrine-related cancer
2022

Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer.

Gynecologic oncology
2022

A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndrome.

Human molecular genetics
2022

Proteus-Like Syndrome: A Rare Phenotype of Phosphatase and Tensin Homolog Hamartoma Tumor Syndrome.

Cureus
2022

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer.

Gastroenterology
2022

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer.

Gastrointestinal endoscopy
2022

Identification and Somatic Characterization of the Germline PTEN Promoter Variant rs34149102 in a Family with Gastrointestinal and Breast Tumors.

Genes
2023

The PTEN hamartoma tumor syndrome: how oral clinicians may save lives.

Clinical advances in periodontics
2022

Validation of a computational phenotype for finding patients eligible for genetic testing for pathogenic PTEN variants across three centers.

Journal of neurodevelopmental disorders
2022

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Familial Tumor Syndromes.

Head and neck pathology
2022

Small integral membrane protein 10 like 1 downregulation enhances differentiation of adipose progenitor cells.

Biochemical and biophysical research communications
2022

Neuroblastoma and cutaneous angiosarcoma in a child with PTEN hamartoma tumor syndrome.

Pediatric blood &amp; cancer
2022

Distinct metabolic profiles associated with autism spectrum disorder versus cancer in individuals with germline PTEN mutations.

NPJ genomic medicine
2022

Phenotypic and molecular characterization of five patients with PIK3CA-related overgrowth spectrum (PROS).

American journal of medical genetics. Part A
2022

Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients.

Orphanet journal of rare diseases
2022

Thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of PTEN Hamartoma Tumor Syndrome in an Adult Patient With a Novel RECQL4 Mutation.

Anticancer research
2022

PTEN hamartoma tumor syndrome in childhood and adolescence-a comprehensive review and presentation of the German pediatric guideline.

Molecular and cellular pediatrics
2023

Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study.

Journal of the American Academy of Dermatology
2021

Genotypic and Phenotypic Characteristics of Hereditary Colorectal Cancer.

Annals of coloproctology
2021

Lateralized and Segmental Overgrowth in Children.

Cancers
2021

Overlapping Phenotypic Features of PTEN Hamartoma Tumor Syndrome and Birt-Hogg-Dubé Syndrome.

Cutis
2021

Cowden's syndrome diagnosed through oral lesions: A case report.

Journal of clinical and experimental dentistry
2022

Proteus Syndrome: Case Report with Anatomopathological Correlation.

Fetal and pediatric pathology
2022

Formation of a de novo intracranial arteriovenous fistula in a child with PTEN hamartoma tumor syndrome.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2021

PTEN Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis.

Frontiers in medicine
2021

Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models.

Frontiers in neural circuits
2021

PTEN regulates adipose progenitor cell growth, differentiation, and replicative aging.

The Journal of biological chemistry
2021

BCG Vaccine-Associated Complications in Patients with PTEN Hamartoma Tumor Syndrome.

Journal of clinical immunology
2021

Prevalence and clinical/molecular characteristics of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly.

Molecular genetics &amp; genomic medicine
2021

Bannayan-Riley-Ruvalcaba syndrome with gingival hyperpigmentation and facial papules.

Pediatric dermatology
2021

Interplay Between Class II HLA Genotypes and the Microbiome and Immune Phenotypes in Individuals With PTEN Hamartoma Tumor Syndrome.

JCO precision oncology
2022

Endoscopic Findings in Patients With PTEN Hamartoma Tumor Syndrome Undergoing Surveillance.

Journal of clinical gastroenterology
2021

PTEN Hamartoma Tumor Syndrome/Cowden Syndrome: Genomics, Oncogenesis, and Imaging Review for Associated Lesions and Malignancy.

Cancers
2021

"Thyroid nodular disease and PTEN mutation in a multicentre series of children with PTEN hamartoma tumor syndrome (PHTS)".

Endocrine
2021

Hamartomatous polyposis syndrome associated malignancies: Risk, pathogenesis and endoscopic surveillance.

Journal of digestive diseases
2021

Distinguishing between PTEN clinical phenotypes through mutation analysis.

Computational and structural biotechnology journal
2020

The Clinical Spectrum of PTEN Hamartoma Tumor Syndrome: Exploring the Value of Thyroid Surveillance.

Hormone research in paediatrics
2021

A randomized double-blind controlled trial of everolimus in individuals with PTEN mutations: Study design and statistical considerations.

Contemporary clinical trials communications
2021

Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates.

Endocrine pathology
2021

Colorectal polyposis as a clue to the diagnosis of Cowden syndrome: Report of two cases and literature review.

Pathology, research and practice
2020

Characterization and Childhood Tumor Risk Assessment of Genetic and Epigenetic Syndromes Associated With Lateralized Overgrowth.

Frontiers in pediatrics
2021

Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome.

The Journal of clinical endocrinology and metabolism
2021

PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female.

Urology
2021

A review on age-related cancer risks in PTEN hamartoma tumor syndrome.

Clinical genetics
2020

Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome.

European thyroid journal
2020

Cerebral MRI and Clinical Findings in Children with PTEN Hamartoma Tumor Syndrome: Can Cerebral MRI Scan Help to Establish an Earlier Diagnosis of PHTS in Children?

Cells
2020

Cutaneous lipomas and macrocephaly as early signs of PTEN hamartoma tumor syndrome.

Pediatric dermatology
2020

[Challenges of screening germline predispositions in children].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2020

Germline PTEN mutations are associated with a skewed peripheral immune repertoire in humans and mice.

Human molecular genetics
2020

WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.

The New England journal of medicine
2020

An Integrated Deep-Mutational-Scanning Approach Provides Clinical Insights on PTEN Genotype-Phenotype Relationships.

American journal of human genetics
2020

A Premalignant Cell-Based Model for Functionalization and Classification of PTEN Variants.

Cancer research
2020

PTEN hamartoma tumor syndrome in children: diagnosis based on cutaneous manifestations with a focus on translucent palmoplantar papules.

Journal of the European Academy of Dermatology and Venereology : JEADV
2020

Predominant DICER1 Pathogenic Variants in Pediatric Follicular Thyroid Carcinomas.

Thyroid : official journal of the American Thyroid Association
2020

Infantile macrocephaly and multiple subcutaneous lipomas diagnosed with PTEN hamartoma tumor syndrome: A case report.

Molecular and clinical oncology
2020

Brain morphological analysis in PTEN hamartoma tumor syndrome.

American journal of medical genetics. Part A
2020

Clinical and molecular aspects of PTEN mutations in 10 pediatric patients.

Annals of human genetics
2020

Autism-associated PTEN missense mutation leads to enhanced nuclear localization and neurite outgrowth in an induced pluripotent stem cell line.

The FEBS journal
2020

Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations.

JAMA network open
2020

Genome sequencing analysis of a family with a child displaying severe abdominal distention and recurrent hypoglycemia.

Molecular genetics &amp; genomic medicine
2020

Imaging of PTEN-related abnormalities in the central nervous system.

Clinical imaging
2020

Biomarker May Predict Cancer Versus Autism Risk in Pten Hamartoma Tumor Syndrome: Decreased levels of fumarate were more strongly associated with autism than cancer in persons with PTEN mutations.

American journal of medical genetics. Part A

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome do hamartoma PTEN.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome do hamartoma PTEN

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Epilepsy in pediatric patients with PTEN hamartoma tumor syndrome: First step in recommendations for clinical management.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society· 2026· PMID 41825102mais citado
  2. Cerebrovascular Malformations Associated With Hereditary Hemorrhagic Telangiectasia and HHT-Like Syndromes: A Comparative Overview.
    European journal of neurology· 2026· PMID 41704211mais citado
  3. Effects of bariatric surgery in individuals with PTEN Hamartoma Tumor Syndrome (PHTS): A systematic review.
    Obesity facts· 2026· PMID 41849632mais citado
  4. Genomic modifiers of malignant and neurodevelopmental phenotypes in individuals with PTEN hamartoma tumor syndrome.
    NPJ genomic medicine· 2026· PMID 41844650mais citado
  5. Macrocephaly and Characteristic MRI Findings as Early Clues to a Hereditary Overgrowth Syndrome.
    Cureus· 2026· PMID 41717203mais citado
  6. Endocrine and metabolic features of PTEN hamartoma tumor syndrome in childhood: a pediatric case series.
    J Pediatr Endocrinol Metab· 2026· PMID 41966075recente
  7. A Stepwise Approach to Macrocephaly: Clinical Clues to the Rare Diagnosis of PTEN Hamartoma Tumor Syndrome.
    Pediatr Ann· 2026· PMID 41926996recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:306498(Orphanet)
  2. MONDO:0017623(MONDO)
  3. GARD:12800(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q3508737(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome do hamartoma PTEN
Compêndio · Raras BR

Síndrome do hamartoma PTEN

ORPHA:306498 · MONDO:0017623
Prevalência
1-9 / 100 000
Herança
Autosomal dominant
CID-10
Q85.8 · Outras facomatoses não classificadas em outra parte
CID-11
Ensaios
4 ativos
Início
All ages
Prevalência
9.0 (Worldwide)
MedGen
UMLS
C1959582
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades